Allied Market Research

2025

Point Of Care Technology Market

Point of Care Technology Market, by Product Type (Analyzers, Reagents and Consumables, Software and Services), by Portable Analyzers (immunoassay, Hematology, Clinical Chemistry, Coagulation, urinalysis, Blood Glucose Monitoring, Fecal Occult blood Test, Others), by Application (Diagnostics, Therapeutics, Health Monitoring) and, by End-Users (Hospitals and Clinics, Diagnostics Laboratories, Physician Offices, Other End-Users): Opportunity Analysis and Industry Forecast, 2023-2032

LS : Other

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

The Point of care technology market is analyzed at a global, regional, and country levels providing analysis of different segments divided depending on its characteristics such as by Product Type, by Portable Analyzers, by Application, by End-Users.

Point of care technology market Overview

The scope of the report focuses on the qualitative analysis covering drivers, opportunities, challenges, and trends. In addition, it emphasizes on the key strategies adopted by the players. Moreover, the major players operating in the market have been profiled in the report along with their strategic developments, including acquisitions, mergers, products launch, agreements, partnerships, collaborations, joint ventures, research & development investment, and regional expansion of leading companies operating in the market at global and regional levels.

Top Impacting Factors: Market Scenario Analysis, Trends, Drivers, And Impact Analysis

Increase/decline that is witnessed in the demand for Point of care technology market has been analyzed in the study. In addition, the impact of cost on the market growth/decline has been studied and elaborated. Moreover, a cumulative effect of the potential factors are likely to expose a few niche market opportunities that can be capitalized by companies across the globe.

Key companies identified in the report include Roche Diagnostics, Abbott, Bayer, bioMerieux, Siemens, Orchid Diagnostics, Inverness Medical, Lifescan, MediSense, Nova Biomedical

Key Reasons to Buy the Report

  1. Major region/country level quantitative and qualitative analysis

  2. Detailed segment analysis at country level

  3. Key supplier profiling and market share analysis

Free 20% customization and post-sales support

Point of Care Technology Market Report Highlights

Aspects Details
icon_5
By Product Type
  • Analyzers
  • Reagents and Consumables
  • Software and Services
icon_6
By Portable Analyzers
  • immunoassay
  • Hematology
  • Clinical Chemistry
  • Coagulation
  • urinalysis
  • Blood Glucose Monitoring
  • Fecal Occult blood Test
  • Others
icon_7
By Application
  • Diagnostics
  • Therapeutics
  • Health Monitoring
icon_8
By End-Users
  • Hospitals and Clinics
  • Diagnostics Laboratories
  • Physician Offices
  • Other End-Users
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
icon_10
Key Market Players

Lifescan, Roche Diagnostics, Nova Biomedical, Siemens, Inverness Medical, Bayer, Orchid Diagnostics, MediSense, bioMerieux, Abbott

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Point of Care Technology Market

Opportunity Analysis and Industry Forecast, 2023-2032